Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors.

Abstract

The role of breast milk antirotavirus immunoglobulin A (IgA) and trypsin inhibitors in limiting the acquisition of rotavirus infection during the initial 5 days of life was evaluated among 42 exclusively breast-fed hospital-born infants, 22 of whom experienced rotavirus infection. The mean concentrations of antirotavirus IgA (ELISA Units) in the breast milk of mothers of the 22 rotavirus-infected neonates was 130.4 +/- 46.4; the corresponding value in 20 noninfected neonates was 384.3 +/- 328.3 (P less than 0.001). Similarly, the trypsin inhibitory capacity (mumols/mt/ml) of breast milk in the rotavirus-infected group was significantly lower (0.109 +/- 0.095) than that in the noninfected group (0.376 +/- 0.191; P less than 0.001). The trypsin inhibitory capacity of milk showed an inverse correlation with infant stool tryptic activity (P less than 0.01). Our results indicate that the acquisition of rotavirus infection during the early neonatal period depends on the concentrations of antirotavirus IgA and trypsin inhibitors in human milk and that protection is mediated by high levels of these antiviral factors.

• Authors: S Jayashree, M K Bhan, R Kumar, N Bhandari, S Sazawal
• Journal: Journal of medical virology (J Med Virol) Vol. 26 Issue 3 Pg. 333-8 (Nov 1988) ISSN: 0146-6615 [Print] United States
• PMID: 3204368 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibodies, Viral
• Immunoglobulin A
• Trypsin Inhibitors

Topics

• Antibodies, Viral (administration & dosage)
• Breast Feeding
• Humans
• Immunoglobulin A (administration & dosage)
• Infant, Newborn
• Milk, Human (immunology, metabolism)
• Rotavirus Infections (prevention & control)
• Trypsin Inhibitors (metabolism, pharmacology)